CalciMedica (CALC) Short-term Investments (2019 - 2025)
CalciMedica's (CALC) quarterly Short-term Investments came in at $1.5 million in Q4 2025, down 86.06% YoY from $10.7 million in Q4 2024, and down 82.63% on a QoQ basis from $8.6 million in Q3 2025.
CalciMedica (CALC) Short-term Investments (2019 - 2025) Analysis & Trends
CalciMedica (CALC) has 7 years of Short-term Investments data on file, last reported at $1.5 million in Q4 2025.
- Quarterly Short-term Investments fell 86.06% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 86.06% YoY) and the FY2025 annual result came in at $1.5 million, down 86.06% from the prior year.
- Short-term Investments declined to $1.5 million in Q4 2025, from $8.6 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $75.1 million in Q1 2021 to a low of $1.5 million in Q4 2025.
- A 5-year average of $26.2 million and a median of $13.1 million in 2024 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2023 — Short-term Investments tumbled 91.19% — and 2024, when it soared 93.89%.
- Tracing CALC's Short-term Investments over 5 years: stood at $50.3 million in 2021, then sank by 33.49% to $33.5 million in 2022, then tumbled by 82.94% to $5.7 million in 2023, then jumped by 88.05% to $10.7 million in 2024, then tumbled by 86.06% to $1.5 million in 2025.
- The last three Short-term Investments figures came in at $1.5 million (Q4 2025), $8.6 million (Q3 2025), and $12.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 8.61 Mn |
| Jun 30, 2025 | 12.04 Mn |
| Mar 31, 2025 | 12.07 Mn |
| Dec 31, 2024 | 10.73 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Jun 30, 2024 | 14.08 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Dec 31, 2023 | 5.71 Mn |
| Sep 30, 2023 | 2.95 Mn |
| Mar 31, 2023 | 9.78 Mn |
| Sep 30, 2022 | 33.46 Mn |
| Jun 30, 2022 | 36.82 Mn |
| Mar 31, 2022 | 46.92 Mn |
| Dec 31, 2021 | 50.31 Mn |
| Sep 30, 2021 | 61.10 Mn |
| Jun 30, 2021 | 65.72 Mn |
| Mar 31, 2021 | 75.10 Mn |
| Dec 31, 2020 | 61.62 Mn |
| Dec 31, 2019 | 20.09 Mn |